Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Hyper-CVAD plus ofatumumab als eerstelijnsbehandeling bij Ph-negatieve B-cel ALL
aug 2020 | Leukemie